atazanavir sulfate has been researched along with naringin in 1 studies
| Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (naringin) | Trials (naringin) | Recent Studies (post-2010) (naringin) |
|---|---|---|---|---|---|
| 1,102 | 246 | 590 | 925 | 25 | 639 |
| Protein | Taxonomy | atazanavir sulfate (IC50) | naringin (IC50) |
|---|---|---|---|
| ubiquitin-conjugating enzyme E2 N | Homo sapiens (human) | 7.6785 | |
| Aromatase | Homo sapiens (human) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nzuza, S; Owira, PMO; Zondi, S | 1 |
1 other study(ies) available for atazanavir sulfate and naringin
| Article | Year |
|---|---|
Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Atazanavir Sulfate; Blood Glucose; Body Weight; Caspase 3; Caspase 9; Drinking; Fasting; Flavanones; Glucokinase; Glucose Intolerance; HIV Protease; HIV Protease Inhibitors; Homeostasis; Insulin; Insulin Resistance; Liver; Male; Metabolic Syndrome; Pancreas; Rats, Wistar; Saquinavir; Signal Transduction; Uncoupling Protein 2 | 2017 |